CMPX
#2997
Compass Therapeutics, Inc. - Common Stock
2.4 9 USD
-0.01%
Market Price
Secteur: Soins de Santé
Base: USD
Devise de Profit: USD
Range quotidien
Range Annuel
Changement quotidien
-1.19%
Changement Mensuel
+22.66%
Evolution sur 6 mois
-54.23%
Changement Annuel
-28.45%
Clôture Précédente
2.5 2
Open
2.5 1
Low
2.4 8
High
2.5 1
Volume
307
Financials
- Market Capitalization 448.42 M
- Employee 39
- Founded 2014
- CEO N/A
- Website www.compasstherapeutics.com
- Headquarter Delaware, United States
- FIGI BBG00LPXKF25
- Industry Biotechnologies
Chiffre d'affaires total
Résultat net
Bénéfice par action de base (BPA de base)
Dette totale
Flux de trésorerie disponible
Trésorerie et équivalents de trésorerie
ratio cours/bénéfice
-12.74
ratio cours/chiffre d'affaires
—
Related tickers
| # | Nom | Prix | 24h % | 7 jours % | 1M % | 1 an % | Cap Boursière | 7 Derniers Jours | |
|---|---|---|---|---|---|---|---|---|---|
| 2977 |  DNA Ginkgo Bioworks Holdings, Inc. Class A Common Stock | 6.93 USD | -4.68% | -4.28% | -10.00% | -21.96% | 445.88 M USD | ||
| 2982 |  AGMB AgomAb Therapeutics NV - ADRs representing one | 13.30 USD | -3.90% | +0.45% | +6.06% | -9.52% | 454.42 M USD | ||
| 3017 |  AVIR Atea Pharmaceuticals, Inc. - common stock | 5.45 USD | -1.09% | -1.45% | +23.30% | +69.78% | 437.12 M USD | ||
| 3041 |  LRMR Larimar Therapeutics, Inc. - Common Stock | 4.03 USD | -0.49% | -2.66% | +5.77% | +2.81% | 418.65 M USD |